E-Rx Prior Authorization Workflow Changes

The Federal Trade Commission (FTC) Eyeglass Rule, officially titled 16 CFR Part 456, is a regulation that mandates eyecare providers to provide patients with a copy of their eyeglass prescription immediately after an eye examination. This rule applies regardless of whether the patient requests the prescription, and even if the examination does not indicate a change in the prescription.   The FTC Eyeglass Rule will go into effect September 2024.   Rule Highlights: Automatic Release of Prescription: After completing an eye exam, you must provide the patient with a copy of their eyeglass prescription, even if they do not ask for it. No Conditions or

Our support operations have been fully restored. Services for our credit card processing partner Nexio have also been fully restored. Eligibility checks for most carriers have been restored as well. A banner in the PM will provide status updates for the remaining carriers. We thank you for your patience and apologize for the inconvenience.

 A software update from the cybersecurity company CrowdStrike has inadvertently disrupted IT systems globally. Although most of our systems were unaffected, our primary remote support tool (LogMeIn Rescue) is currently offline. Consequently, our remote support capabilities have been impacted. Our support team is unable to access customer systems using this tool. However, we can connect to remote systems using an alternative, customer-initiated tool. As a result, we are unable to perform certain remote tasks, which may lead to support delays and cancellations. Additionally, our credit card processing partner, Nexio, is currently unable to process credit card transactions, and certain eligibility checks are failing. We thank

We are excited to introduce NewCrop Rx v2!   Our development team has been collaborating closely with our ePrescribing vendor to bring you the latest version of NewCrop Rx. The new platform is designed to enhance usability and reliability, offering a host of new features including: A fresh, modern, and intuitive interface. Real-time benefits information (including alternative drug options). Customized SIG builders. New drop-down menus and much more! To ensure a seamless transition, please review the Migration Guide prior to your transition.   To assist you in mastering the ePrescribing process and optimizing your transition experience, the following resources are also available: Get Started Guide

As temperatures rise and flowers bloom, remember to review your MIPS figures before diving into the pool! We suggest scheduling regular meetings with your Verana Practice Experience Manager (PEM) to review your 2024 data and keeping a close eye on your Quality Dashboard to ensure a seamless end-of-year attestation process. This is an ideal opportunity to make any essential workflow adjustments and enhance your performance for the year. If you intend to attest to PI for 2024, your attestation period must commence no later than July 4, 2024. MIPS 2024 Deadlines (subject to change) July 4, 2024 – First day of the final 180-day attestation

CMS Announces Reopening of 2023 MIPS EUC Application in Response to the Change Healthcare Cyberattack In response to the Change Healthcare cyberattack in late February, the Centers for Medicare & Medicaid Services (CMS) extended the data submission deadline and is now reopening the 2023 Merit-based Incentive Payment System (MIPS) Extreme and Uncontrollable Circumstances (EUC) Exception Application to provide relief to MIPS-eligible clinicians impacted by this cybersecurity incident. The application will be open for the remainder of the extended data submission period, which closes April 15, 2024, at 8 p.m. ET. Details can be found here. Who can submit an application for EUC during this extension?